Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics.
Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review
Association of Cardiovascular Disease With Respiratory Disease
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
The conductive function of biopolymer corrects myocardial scar conduction blockage and resynchronizes contraction to prevent heart failure
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.